Detailed Narrative
Robust Q3 FY26 Performance Despite Headwinds
SRF delivered a healthy performance in Q3 FY26, with gross operating revenue growing 6% to INR3,713 crore. EBIT saw a significant 23% year-on-year increase, reaching INR653 crore, up from INR529 crore in Q3 FY25. Net Profit After Tax (PAT) expanded by an impressive 60% year-on-year to INR433 crore, reflecting improved operational efficiency and disciplined cost management amidst global uncertainties.
Chemicals Business Driven by Fluorochemicals, Specialty Faces Pressure
The Chemicals Business reported a strong revenue growth of 22%, increasing from INR1,496 crore in Q3 FY25 to INR1,825 crore in Q3 FY26. This growth was primarily fueled by higher refrigerant volumes and enhanced operational efficiencies in Fluorochemicals, which had a record quarter. However, the Specialty Chemicals segment continued to face persistent pricing pressure from Chinese competitors, leading SRF to prioritize market share and volumes over aggressive pricing.
Strategic Expansion into Pharma Segment
To mitigate risks associated with the cyclical nature of the agro-chemical business, SRF is accelerating its expansion into the pharma segment. The company is investing INR180 crore in a second pharma intermediate plant at its Dahej site, which is expected to be commissioned within the next 8 months. This move aims to increase the pharma business's contribution to at least 20% of the total specialty chemicals portfolio, leveraging a robust pipeline of new molecules and growing customer base.
New Generation Gases and Odisha Site Development
SRF is making significant progress on its next-generation refrigerant gases project, which will be housed at a new site in Odisha. The company has applied for necessary regulatory clearances and anticipates initial investments of INR1,500 crore to INR2,000 crore for this site in FY27. This strategic investment aligns with the inevitable global transition to new generation gases under the Kigali Amendment, positioning SRF for long-term growth in this evolving market.
Performance Films & Foils Navigates Competitive Landscape
The Performance Films & Foils business experienced a 3% year-on-year revenue decline to INR1,342 crore, although EBIT improved slightly to INR95 crore from INR90 crore in Q3 FY25. This segment faced challenges from lower BOPET and BOPP volumes in the domestic market and sustained competitive pressure from cheaper imports in international markets. Encouragingly, recent Chinese mandates to cut BOPET capacity by 20% have led to some price improvement, with further cuts expected post-Lunar holidays.
Capital Allocation and Shareholder Returns
The Board approved a second interim dividend of INR5 per share, resulting in a cash outflow of INR148.21 crore, following a previous INR4 per share dividend. SRF maintains a strong capex outlook, with significant investments planned for the new pharma plant and the Odisha site for new generation gases. While global interest rate reductions are beneficial, the company noted a negative impact from rupee-dollar hedges due to unprecedented🌐 rupee depreciation, though a weak rupee is generally favorable for its export-oriented business.